- Home
- MTVA vs ATER Comparison
MTVA vs ATER Comparison
Compare MTVA & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- ATER
- Stock Information
- Founded
- MTVA 2014
- ATER 2014
- Country
- MTVA United States
- ATER United States
- Employees
- MTVA N/A
- ATER N/A
- Industry
- MTVA
- ATER Home Furnishings
- Sector
- MTVA
- ATER Consumer Discretionary
- Exchange
- MTVA NYSE
- ATER Nasdaq
- Market Cap
- MTVA 15.1M
- ATER 15.5M
- IPO Year
- MTVA N/A
- ATER N/A
- Fundamental
- Price
- MTVA $0.69
- ATER $1.43
- Analyst Decision
- MTVA Strong Buy
- ATER
- Analyst Count
- MTVA 2
- ATER 0
- Target Price
- MTVA $7.50
- ATER N/A
- AVG Volume (30 Days)
- MTVA 599.8K
- ATER 166.5K
- Earning Date
- MTVA 05-14-2025
- ATER 05-14-2025
- Dividend Yield
- MTVA N/A
- ATER N/A
- EPS Growth
- MTVA N/A
- ATER N/A
- EPS
- MTVA N/A
- ATER N/A
- Revenue
- MTVA N/A
- ATER $94,191,000.00
- Revenue This Year
- MTVA N/A
- ATER N/A
- Revenue Next Year
- MTVA N/A
- ATER $7.48
- P/E Ratio
- MTVA N/A
- ATER N/A
- Revenue Growth
- MTVA N/A
- ATER N/A
- 52 Week Low
- MTVA $0.63
- ATER $1.36
- 52 Week High
- MTVA $5.30
- ATER $3.84
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- ATER 31.95
- Support Level
- MTVA N/A
- ATER $1.59
- Resistance Level
- MTVA N/A
- ATER $1.54
- Average True Range (ATR)
- MTVA 0.00
- ATER 0.12
- MACD
- MTVA 0.00
- ATER -0.03
- Stochastic Oscillator
- MTVA 0.00
- ATER 14.29
About MTVA METAVIA INC
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.